WOCKHARDT
Back to Balance Sheet
|
WOCKHARDT Last 5 Year Total Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹7,586 Cr | ₹7,070 Cr | ₹7,075 Cr | ₹7,670 Cr | ₹7,376 Cr |
What is the latest Total Liabilities ratio of WOCKHARDT ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹7,586 Cr |
| Mar2024 | ₹7,070 Cr |
| Mar2023 | ₹7,075 Cr |
| Mar2022 | ₹7,670 Cr |
| Mar2021 | ₹7,376 Cr |
How is Total Liabilities of WOCKHARDT Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹7,586 Cr | 7.30 | |
| Mar2024 | ₹7,070 Cr | -0.07 | |
| Mar2023 | ₹7,075 Cr | -7.76 | |
| Mar2022 | ₹7,670 Cr | 3.99 | |
| Mar2021 | ₹7,376 Cr | - | |
Compare Total Liabilities of peers of WOCKHARDT
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| WOCKHARDT | ₹22,382.8 Cr | -0.8% | -0.2% | 6.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹386,773.0 Cr | -6.8% | -7.6% | -4.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹159,540.0 Cr | -6.6% | -5.8% | 4.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹134,529.0 Cr | 0.9% | 5.7% | 27.3% | Stock Analytics | |
| CIPLA | ₹111,299.0 Cr | -4.8% | -8.1% | -3.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,393.0 Cr | -2% | -8.8% | -12.9% | Stock Analytics | |
WOCKHARDT Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| WOCKHARDT | -0.8% |
-0.2% |
6.1% |
| SENSEX | -2% |
-2.8% |
7.4% |
You may also like the below Video Courses